CEU CMC Vellore
CEU CMC Vellore
  • 140
  • 36 562

วีดีโอ

ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID
มุมมอง 64 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - IV) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID
มุมมอง 84 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - III) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID
มุมมอง 147 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - II) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID
มุมมอง 277 ชั่วโมงที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, CMC VELLORE ARTIFICIAL INTELLIGENCE IN MEDICINE (PART - I) _ DR. THAMBU DAVID VENUE : CEU, CMC VELLORE
CONSORT - AI CHECKLIST FOR AN RCT USING AI_ DR. JAHNAWIRAVINDRA MARATHE
มุมมอง 3114 วันที่ผ่านมา
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CONSORT - AI CHECKLIST FOR AN RCT USING AI APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : DR. THAMBU DAVID DATE : Nov 02, 2024 VENUE : CEU, CMC VELLORE
AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS_ DR. JAHNAWIRAVINDRA MARATHE
มุมมอง 53หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - AMSTAR and CheckMAP TOOLS FOR AN IPD META-ANALYSIS APPRAISER : DR. JAHNAWI RAVINDRA MARATHE MODERATOR : Prof. PRATHAP THARYAN DATE : OCTOBER 26, 2024 VENUE : CEU, CMC VELLORE
PROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL _ DR. JAHNAWI RAVINDRA MARATHE
มุมมอง 84หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CPROPENSITY SCORE -A COHORT STUDY CRITICAL APPRAISAL APPRAISER : DR. JAHNAWI RAVINDRA MARATHE (Consultant - General Medicine) MODERATORS : Prof. L. JEYASEELAN (Professor of Biostatistics, Mohammad Bin Rashid University, Dubai, UAE) & Ms. MALAVIKA (Centre for Trials Research, Cardiff university) DATE : OCTO...
CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD- DR.SAKSHI PARSARAMPURIA
มุมมอง 53หลายเดือนก่อน
CLINICAL EPIDEMIOLOGY UNIT, COCHRANE CMC VELLORE AFFILIATE SHORT COURSE IN EPIDEMIOLOGY - CRITICAL APPRAISAL OF A DIAGNOSTIC PREDICTION MODEL STUDY TRIPOD & STARD APPRAISER : DR.SAKSHI PARSARAMPURIA MODERATOR : DR. VIGNESH KUMAR C DATE : OCTOBER 12, 2024 VENUE : CEU, CMC VELLORE
WHY AN RCT _ DR SHRIKANT BANGDIWALA
มุมมอง 34หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
TYPES OF ANALYSIS _ DR SHRIKANT BANGDIWALA
มุมมอง 58หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
TYPE OF HYPOTHESIS _ DR SHRIKANT BANGDIWALA
มุมมอง 47หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
SYSTEMATIC REVIEW _ DR THAMBU DAVID
มุมมอง 42หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
STUDY DESIGNS _ DR THAMBU DAVID
มุมมอง 104หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
SECONDARY ANALYSIS OF A CLINICAL TRIAL _ DR SHRIKANT BANGDIWALA
มุมมอง 16หลายเดือนก่อน
Clinical Trials Course “Design, Analyses And Interpretation” December 04-06, 2023 Organized By Clinical Epidemiology Unit & Cochrane CMC Vellore Affiliate Christian Medical College, Vellore In collaboration with the Cochrane Canada Centre and Population Health Research Institute, McMaster University, Ontario, Canada.
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
มุมมอง 54หลายเดือนก่อน
PHASE I AND PHASE II DESIGNS _ DR MAHESH IYER
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
มุมมอง 26หลายเดือนก่อน
OPERATIONAL DESIGN CONSIDERATIONS IN RCTS _ DR SHRIKANT I BANGDIWALA
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
มุมมอง 32หลายเดือนก่อน
INTERIM ANALYSIS IN A CLINICAL TRIAL _ DR SHRIKANT I BANGDIWALA
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
มุมมอง 21หลายเดือนก่อน
DEFINING THE STUDY OUTCOME _ DR SHRIKANT I BANGDIWALA
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
มุมมอง 90หลายเดือนก่อน
CRITICAL APPRAISAL OF A RANDOMIZED CONTROL TRIAL _ DR THAMBU DAVID
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
มุมมอง 62หลายเดือนก่อน
CONFIDENCE INTERVALS _ DR. L. JEYASEELAN
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
มุมมอง 79หลายเดือนก่อน
CONDITION POWER IN INTERIM ANALYSES OF A CLINICAL TRIAL _ DR. L. JEYASEELAN
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
มุมมอง 47หลายเดือนก่อน
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART II _ DR. SHRIKANT I. BANGDIWALA
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA
มุมมอง 35หลายเดือนก่อน
COMMON RCT DESIGNS IN PHASE IIB AND III CLINICAL TRIALS - PART I _ DR. SHRIKANT I. BANGDIWALA
CRITICAL APPRAISAL OF A CROSS SECTIONAL STUDY _ DR.SAKSHI PARSARAMPURIA
มุมมอง 34หลายเดือนก่อน
CRITICAL APPRAISAL OF A CROSS SECTIONAL STUDY _ DR.SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF HEALTH INFORMATION ON SOCIAL PLATFORMS - DR.SAKSHI PARSARAMPURIA
มุมมอง 332 หลายเดือนก่อน
CRITICAL APPRAISAL OF HEALTH INFORMATION ON SOCIAL PLATFORMS - DR.SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF A CLUSTER RANDOMIZED CONTROLLED TRIAL USING RoB2 TOOL _DR. DAVID MATHEW DANIEL
มุมมอง 252 หลายเดือนก่อน
CRITICAL APPRAISAL OF A CLUSTER RANDOMIZED CONTROLLED TRIAL USING RoB2 TOOL _DR. DAVID MATHEW DANIEL
CRITICAL APPRAISAL OF A QUALITATIVE STUDY _ DR. SAKSHI PARSARAMPURIA
มุมมอง 312 หลายเดือนก่อน
CRITICAL APPRAISAL OF A QUALITATIVE STUDY _ DR. SAKSHI PARSARAMPURIA
CRITICAL APPRAISAL OF A GUIDELINE - Dr. David Mathew Daniel
มุมมอง 972 หลายเดือนก่อน
CRITICAL APPRAISAL OF A GUIDELINE - Dr. David Mathew Daniel
CRITICAL APPRAISAL OF A RANDOMIZED CONTROLLED TRIAL WITH A WIN RATIO - Dr. David Mathew Daniel
มุมมอง 872 หลายเดือนก่อน
CRITICAL APPRAISAL OF A RANDOMIZED CONTROLLED TRIAL WITH A WIN RATIO - Dr. David Mathew Daniel

ความคิดเห็น

  • @timchambers5242
    @timchambers5242 หลายเดือนก่อน

    What do you think of the PACE trial as an example of what not to do? No significant benefit to objective measures but it's promoted by it's authors&supporters as evidence for recommending their cure. th-cam.com/video/PRCQ-kIxQyY/w-d-xo.htmlsi=Mf_bLDqfkU8FQzk_

  • @РодионЧаускин
    @РодионЧаускин หลายเดือนก่อน

    Lee George Davis Timothy Anderson Susan

  • @Torecan
    @Torecan 5 หลายเดือนก่อน

    Thank you very much. I have three questions 1) In the R code it is shown in minute 48, what you call the cens variable is coded 0, 1, 2, and 3, isnt' it? Thus 2 and 3 events are automatically considered competing risks/events when you set failcode is 1 (default), isn't it? 2) You then use cens2, why that change? 3) Third and last question, for a cathegorical covariate with more than two categories you need to convert it into dummies variables, the crr doesn't do the job automatically, does it?

  • @dr.strangelove8846
    @dr.strangelove8846 6 หลายเดือนก่อน

    Great video Dr. Horny Was wondering if Markov models are in use currently for drug approval process ? My question is this: Is FDAs drug approval process in clinical trials system called “ golden standard” can be improved in cost and time for all stakeholders ?

  • @festusakwasiboakye1582
    @festusakwasiboakye1582 ปีที่แล้ว

    Thank you for the video. It is saving me here

  • @dsin7322
    @dsin7322 ปีที่แล้ว

    Hi, is it possible to get the PPT.

  • @marymagoya1999
    @marymagoya1999 2 ปีที่แล้ว

    This is very helpful

  • @rodneychisha9972
    @rodneychisha9972 2 ปีที่แล้ว

    Thanks Dr.Michal for this life-saving video.It couldn't be more timely

  • @sushilkumarshukla3797
    @sushilkumarshukla3797 3 ปีที่แล้ว

    I am getting Data_object error while doing ROC analysis of Comparison. What is wrong in this?

  • @AnilKumar-ti8dy
    @AnilKumar-ti8dy 3 ปีที่แล้ว

    Very good initiative by Prof. Jeyaseelan.

  • @rollinsraviv8273
    @rollinsraviv8273 3 ปีที่แล้ว

    vnp33 vyn.fyi

  • @sriragaresorts6051
    @sriragaresorts6051 8 ปีที่แล้ว

    Good informative video. visit us Yelagiri resorts, Hotels in yelagiri

  • @elizabethvinod7894
    @elizabethvinod7894 10 ปีที่แล้ว

    Thank you sir, was a great opportunity for us to present. Elizabeth Vinod

  • @roymercy64
    @roymercy64 10 ปีที่แล้ว

    Great programme Congrats Thambu and co.